ADAG (Adagene Inc.) Short-Term Debt to Capital
This price chart on GURU.Markets shows the 0.04 metric, highlighting the market position of Adagene (ADAG). Adagene leverages the SAFEbody AI system to develop selective antibodies, which provides significant pricing power. Management is focused on verifying these methods through clinical trials. The risks of narrow specialization are mitigated through strategic alliances with global pharmaceutical behemoths.
Analytical breakdowns for Adagene
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Adagene Inc.
By monetizing patents through alliances with pharma behemoths, Adagene minimizes operational risks, which is reflected in its liability structure. This metric correlates the amount of loans maturing within one year with equity, allowing for the identification of hidden default threats during market panics. Analyzing the volume of short-term loans relative to capital helps investors separate emotional price fluctuations from the issuer's actual solvency.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN - Short-Term Debt to Capital|PVLA: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SVRA|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital AnaptysBio Inc|Short-Term Debt to Capital ATXS|enGene Corp (ENGN) - Short-Term Indebtedness to Equity|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Current Liabilities to Capital|ACRS - Short-Term Debt to Equity|KYTX (Kyverna Therapeutics Inc.) - Short-Term Debt to Capital Ratio|TLSA: Short-Term Debt to Capital|Current Liabilities to Capital Cabaletta Bio Inc (CABA)|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|Short-Term Debt to Capital theratech.com|Short-Term Debt to Capital AVTX|Eledon Pharmaceuticals Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital AGEN (Agenus Inc)|Short-Term Debt to Capital Climb Bio, Inc CLYM|Zura Bio - Short-Term Debt to Capital|Short-Term Indebtedness to Equity atyrpharma.com (ATYR)|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Current Liabilities to Equity STTK (Shattuck Labs)|EQ (Equillium Inc) - Short-Term Debt to Capital|CNTB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital IMUX|Short-Term Debt to Capital atarabio.com (ATRA)|Short-Term Debt to Equity InflaRx IFRX|Ratio of Short-Term Indebtedness to Capital XFOR|ACET - Short-Term Debt to Equity|Celularity Inc. (CELU) - Short-Term Debt to Equity Ratio|INMB: Short-Term Debt to Capital|barinthusbio.com (BRNS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio KZR|SABS: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|GOVX - Short-Term Debt to Equity Ratio|EDSA - Short-Term Debt to Equity|iBio Inc (IBIO) - Short-Term Debt to Equity Ratio|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Capital Ratio HCWB (HCW Biologics Inc)|Short-Term Debt to Capital APVO|AIM - Current Liabilities to Capital|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND (reshapelifesciences.com) - Short-Term Debt to Capital Ratio|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|SCNI (Scinai) - Short-Term Debt to Capital|CALI - Short-Term Indebtedness to Equity|Short-Term Debt to Capital AFMD|ALLK - Current Liabilities to Capital|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS: Short-Term Debt to Capital Ratio|iTeos - Short-Term Debt to Capital|Current Liabilities to Capital Ocean Biomedical Corp|TCBP: Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital